The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel … (NCT03535883) | Clinical Trial Compass
CompletedNot Applicable
The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants
United States590 participantsStarted 2017-10-30
Plain-language summary
To assess risks of bleeding in those individuals receiving Novel Oral Anti-Coagulant (NOAC) medications, admitted to the hospital and require thoracentesis, chest tube or tunneled pleural catheter placement.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age \> 18 y/o
. Unilateral or bilateral pleural effusion
. Ability to provide consent or consent given for the procedure and research study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study specifically looked at bleeding risk during procedures like thoracentesis and tunneled pleural catheters in people taking newer blood thinners like apixaban or rivaroxaban — do my specific medications put me at higher or lower risk based on what this trial found?
2Since this trial is now completed, has my doctor seen or reviewed the results, and do those findings change how they'd approach draining my pleural effusion while I'm on a novel oral anticoagulant?
3The study compared different pleural procedures — thoracentesis, tunneled pleural catheters, and chest tubes — so which of those options would my doctor recommend for me, and how does my blood thinner factor into that choice?
4Would my doctor consider pausing or adjusting my anticoagulant before any pleural drainage procedure, and does the evidence from this trial support doing that or not?
5Are there situations where standard care — meaning skipping a procedure or managing my pleural effusion another way — might be safer for me than any of the interventional options studied in this trial?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.